Identification and Validation of Plasma-Based Lipid Biomarkers for Early Alzheimer’s Disease in the Unique, Primarily Hispanic, South Texas Population

2023, 2024

There is an urgent need to develop tools for convenient and cost-effective early diagnosis of Alzheimer’s disease and to monitor its progression. In this proposal, we plan to use advanced technology to measure previously undetermined molecules in the blood and cerebrospinal fluid as biomarkers for early diagnosis of Alzheimer’s disease. Notably, we will assess a large and unique group of South Texas participants composed of about half Hispanic and half non-Hispanic White individuals. This study is novel in at least three aspects, including the technology used, the molecules assessed and the population investigated.

Bernard Fongang Biomarkers/Diagnostics/Studies of Risk & Resilience Foundational Juan Pablo Palavicini Tiffany F. Kautz Xianlin Han

Related Content:

Utility of Blood-Based Markers for Predicting Amyloid-Related Imaging Abnormalities and Their Course in Mild Cognitive Impairment and Alzheimer’s Disease Subjects Undergoing Routine Clinical Treatment with Amyloid-Directed Antibodies P. Murali Doraiswamy 2024-01-12 Characterization of the Longitudinal Trajectories of the Synaptic Blood Marker Beta-Synuclein during Alzheimer’s Disease Pathogenesis and Improvement of the Measurement Procedure Patrick Oeckl Markus Otto 2023-09-19 Precision Medicine Prediction Model for Alzheimer’s Disease Using Cooperative Learning Approaches for Multi-Omic Data Christoph Lange 2023-05-02 Adding Genomics and Methylomics to Personalized Disease Prediction for Alzheimer’s Disease (EPIC4AD) Lars Bertram Christina M. Lill 2023-02-28 Identification and Validation of Plasma-Based Lipid Biomarkers for Early Alzheimer’s Disease in the Unique, Primarily Hispanic, South Texas Population Xianlin Han Bernard Fongang Juan Pablo Palavicini Tiffany F. Kautz 2023-02-23 Cerebrospinal Fluid Neuroinflammatory Signature in Alzheimer´s Disease and Related Proteopathies Mathias Jucker Stefan Lichtenthaler Stephan Kaeser 2022-11-22 Neuronal Subtype-Specific Modeling of Alzheimer’s Disease by Direct Neuronal Reprogramming of Patient Fibroblasts Andrew S. Yoo 2022-02-17 Targeted Recruitment of Underrepresented Americans for Brain Donation Registration Brain Donor Project 2022-02-10